Parnax Lab Ltd

Standalone results

• Board approved standalone unaudited results for the quarter ended 30 June 2026.
• Single segment: Dealing in Pharmaceutical Formulations; AS 17 not applicable.
• AGM scheduled for September 29, 2026 via VC/OVAM.
• In-principle appointment of M/s Ladha Singhal & Associates as Statutory Auditors till 2031, subject to shareholders' approval.
• Labour Code impact disclosed as Exceptional Items; standalone Rs 3.49 Lakhs for year ended 31 Mar 2026.

Consolidated results

• Consolidated unaudited results include holding company and subsidiary.
• Labour Code impact on consolidated results: Rs 136.93 Lakhs for year ended 31 Mar 2026 under Exceptional Items.
• Limited Review of consolidated results conducted by Statutory Auditors.
• Consolidated results approved by Board; Limited Review completed.
• There are no outstanding defaults on loans and debt securities.

Governance & other notes

• Board meeting held on August 11, 2026; results reviewed by Audit Committee.
• Company operates in one segment: Dealing in Pharmaceutical Formulations.

Transaction details and impact

• Purpose: Exemption under Regulation 10(1)(a)(ii) for inter-se transfer by gift within promoter group.
• Date and parties: transfer on July 20, 2026 from Ila B. Shah to Prakash Shah.
• Shares transferred: 3,61,872 shares.
• Consideration: gift; no monetary consideration.
• Acquirer pre-transaction: 12,01,676 shares (10.46%).
• Acquirer post-transaction: 15,63,548 shares (13.61%).
• Seller pre-transaction: 13,61,872 shares (11.86%).
• Seller post-transaction: 10,00,000 shares (8.71%).
• Total promoter group holding remains 25,63,548 shares (22.32%).
• Promoter group status unchanged; no change in control.
• Filed within 21 working days; fees paid; Annexures attached.
• 10(5) disclosure to stock exchanges filed (June 25, 2026).
• 10(6) disclosure filed (July 24, 2026).
• Acquirer confirms compliance with 10(1)(a)(ii) exemptions.
• Special context: Gift within promoter group; not an open offer trigger.

Transaction details

• Inter-se transfer through gift within Promoter/Promoter Group; exemption under Reg 10(1)(a)(ii) applied.
• Transferor: Baiju Shah (promoter, immediate relative); Acquirer: Mihir Prakash Shah (promoter, acquirer).
• Date of transfer: July 21, 2026; Shares transferred: 3,77,355.

Shareholding impact

• Pre-transaction: Acquirer 7,74,250 shares (9.94%); Seller 13,29,261 shares (11.57%).
• Post-transaction: Acquirer 15,18,605 shares; Seller 9,51,906 shares; total 24,70,511.
• Promoter group's total shareholding remains unchanged; no change in control or promoter status.

Compliance and notes

• Regulatory compliance: report filed within 21 working days; fees paid; exchanges notified.
• Exemption conditions under Reg 10(1)(a)(ii) satisfied.

Resolutions and outcome

• Purpose: Re-appoint Yogesh Varia as Non-Executive Independent Director for a second five-year term.
• Type: Special resolution.
• Result: Approved; total votes polled 3,952,291; in favour 3,949,841; against 2,450; 99.94% in favour.
• Term: Five-year term.
• Independence/experience: Independent; no experience details disclosed.
• Notice: Postal Ballot notice dated July 8, 2026.
• Voting window: Remote e-voting concluded Aug 8, 2026; Scrutinizer report dated Aug 10, 2026.

Resolutions

• Special Resolution approved: re-appoint Yogesh K. Varia as Non-Executive Independent Director.
• Term: five years; effective 28 May 2026 to 27 May 2031.
• Not liable to retire by rotation.
• Outcome: approved by shareholders; passed as Special Resolution.

Director profile

• Yogesh Kantilal Varia, DIN 09186184; role: Non-Executive Independent Director; term until 27 May 2031.
• Experience: over 40 years in pharmaceutical and cosmetics manufacturing.
• Independence: not related to Directors or KMP; shareholding Nil.

Impact on shareholders

• Governance: independent director appointment enhances oversight for five-year term.

Dematerialisation status

• No dematerialisation requests were received in the reporting quarter.
• Securities dematerialised during the period were listed on the stock exchanges where existing issues are listed.
• Physical certificates received for dematerialisation were mutilated and cancelled after verification, with depository name as registered owner.

Purpose

• Seek shareholder approval for re-appointment of Yogesh Kantilal Varia as Non-Executive Independent Director via postal ballot.

Resolution

• Item 01: Special resolution to re-appoint Yogesh Varia as Non-Executive Independent Director for 5 years (2026–2031).

Key terms

• Term: 5 years; start 28 May 2026; end 27 May 2031.

Trading Window Closure

• Trading Window closed for all insiders, designated persons and their immediate relatives from 01 July 2026.
• Closure for consideration of unaudited financial results for the quarter ended 30 June 2026.
• Trading Window reopens 48 hours after results are publicly available.